![](/img/cover-not-exists.png)
A phase II, pharmacokinetic, and biologic study of semaxanib and thalidomide in patients with metastatic melanoma
Monica M. Mita, Eric K. Rowinsky, Leonardo Forero, S. Gail Eckhart, Elzbieta Izbicka, Geoffrey R. Weiss, Muralidhar Beeram, Alain C. Mita, Johann S. de Bono, Anthony W. Tolcher, Lisa A. Hammond, PaulVolume:
59
Language:
english
Pages:
10
DOI:
10.1007/s00280-006-0255-0
Date:
February, 2007
File:
PDF, 353 KB
english, 2007